Low-dose vemurafenib monotherapy in BRAFV600E-mutated Erdheim-Chester disease

被引:8
|
作者
Ruan, Gordon J. [1 ]
Hazim, Antonious [1 ]
Abeykoon, Jithma P. [1 ]
Scheckel, Caleb [1 ]
Vassallo, Robert [2 ]
Ryu, Jay H. [2 ]
Tobin, W. Oliver [3 ]
Koster, Matthew J. [4 ]
Bennani, N. Nora [1 ]
Rech, Karen L. [5 ]
Young, Jason R. [6 ]
Shah, Mithun V. [1 ]
Goyal, Gaurav [7 ]
Go, Ronald S. [1 ]
机构
[1] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA
[3] Mayo Clin, Dept Neurol, Rochester, MN USA
[4] Mayo Clin, Div Rheumatol, Rochester, MN USA
[5] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[6] Mayo Clin, Dept Radiol, Rochester, MN USA
[7] Univ Alabama Birmingham, Div Hematol Oncol, 2000 6th Ave S, Birmingham, AL 35233 USA
关键词
BRAF;
D O I
10.1080/10428194.2020.1783447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2733 / 2737
页数:5
相关论文
共 50 条
  • [1] Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With BRAFV600E-Mutated Erdheim-Chester Disease
    Haroche, Julien
    Cohen-Aubart, Fleur
    Emile, Jean-Francois
    Maksud, Philippe
    Drier, Aurelie
    Toledano, Dan
    Barete, Stephane
    Charlotte, Frederic
    Cluzel, Philippe
    Donadieu, Jean
    Benameur, Neila
    Grenier, Philippe A.
    Besnard, Sophie
    Ory, Jean-Paul
    Lifermann, Francois
    Idbaih, Ahmed
    Granel, Brigitte
    Graffin, Bruno
    Hervier, Baptiste
    Arnaud, Laurent
    Amoura, Zahir
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) : 411 - U52
  • [2] Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing BRAFV600E-Mutated Erdheim-Chester Disease: A Case Report
    Razanamahery, Jerome
    Abdallahoui, Maroua
    Chabridon, Guillaume
    Fromont, Agnes
    Tarris, Georges
    Idbaih, Ahmed
    Comby, Pierre Olivier
    Godard, Francois
    Haroche, Julien
    Audia, Sylvain
    Bonnotte, Bernard
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Encorafenib for Erdheim-Chester disease harboring the BRAFV600E mutation
    Wada, Fumiya
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S359 - S359
  • [4] FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the BRAFV600 Mutation
    Oneal, Patricia A.
    Kwitkowski, Virginia
    Luo, Lola
    Shen, Yuan Li
    Subramaniam, Sriram
    Shord, Stacy
    Goldberg, Kirsten B.
    McKee, Amy E.
    Kaminskas, Edvardas
    Farrell, Ann
    Pazdu, Richard
    [J]. ONCOLOGIST, 2018, 23 (12): : 1520 - 1524
  • [5] A cytologic diagnosis of BRAFV600E Erdheim-Chester disease on pericardial fluid
    Chasseur, P.
    Kyriakopoulou, M.
    Vokaer, B.
    Beukinga, I.
    Arroyo, R. Casado
    Cogan, E.
    Couturier, B.
    [J]. ACTA CLINICA BELGICA, 2017, 72 (05) : 369 - 371
  • [6] Significant response to dabrafenib in a patient with Erdheim-Chester disease with BRAFV600E mutation
    Verschelden, Gil
    Van Laethem, Johan
    Velkeniers, Brigitte
    Ilsen, Bart
    Noeparast, Amir
    De Greve, Jacques
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (06): : 386 - 388
  • [7] Sirolimus monotherapy for Erdheim-Chester disease
    van Bommel, Eric F. H.
    van der Zijden, Mark A.
    Gregoor, Peter J. H. Smak
    Hendriksz, Tadek R.
    Ho-Han, Shiuw H.
    Westenend, Pieter J.
    [J]. ACTA ONCOLOGICA, 2019, 58 (06) : 901 - 905
  • [8] Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib
    Car, Iris
    Dittmann, Antje
    Klobucar, Marko
    Grbcic, Petra
    Pavelic, Sandra Kraljevic
    Sedic, Mirela
    [J]. BIOLOGY-BASEL, 2023, 12 (04):
  • [9] Sustained Response to Vemurafenib in a BRAFV600E-Mutated Anaplastic Thyroid Carcinoma Patient
    Prager, Gerald W.
    Koperek, Oskar
    Mayerhoefer, Marius E.
    Muellauer, Leonhard
    Wrba, Fritz
    Niederle, Bruno
    Zielinski, Christoph C.
    Raderer, Markus
    [J]. THYROID, 2016, 26 (10) : 1515 - 1516
  • [10] Dramatic response to encorafenib in a patient with Erdheim-Chester disease harboring the BRAFV600E mutation
    Wada, Fumiya
    Hiramoto, Nobuhiro
    Yamashita, Daisuke
    Hara, Shigeo
    Furukawa, Yutaka
    Ishii, Junko
    Nagata, Kazuma
    Nannya, Yasuhito
    Ogawa, Seishi
    Ishikawa, Takayuki
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (08) : E295 - E298